IMS Country Review 2017: Netherlands

  • ID: 596404
  • Report
  • Region: Netherlands, Holland
  • 69 Pages
  • IMS Health
1 of 5

FEATURED COMPANIES

  • Actavis
  • Astrazeneca
  • Fisher Farma
  • Medcor
  • Organon Ned Bv
  • Ratiopharm
  • MORE
IMS Country Review™ 2017 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Key Benefits:
  • Targeted national sales analysis by company, product and therapy areas, allowing you to understand the pharmaceutical performance of the country.
  • Synopsis of the healthcare system and relevant pharmaceutical issues, based on primary research gathered by the IMS country experts.
  • Standardised comparable data against which the industry is measured, stemming from accurate and reliable IMS audited year-end sales data.
Includes useful measures:
  • US$ sales
  • 5 year growth in US $ and local currency dollar (eliminating inaccuracies due to exchange rate fluctuations)
  • Evolution Index
  • market share
  • Detailed information file allowing a thorough understanding of the data values and definitions, the universe/country abbreviations, and the EphMRA anatomical therapeutic classification
  • Cost-effective strategic analysis tool that will provide the essential insights needed to get insights into a country market of interest
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Actavis
  • Astrazeneca
  • Fisher Farma
  • Medcor
  • Organon Ned Bv
  • Ratiopharm
  • MORE
These Country Review comprises 2 sections:

1. Qualitative country overview, featuring consistent sections on:
  • Market Trends
  • Healthcare Provision
  • Prescribing Policy
  • Pricing System
  • Regulatory Environment
  • Industr y Environment
  • Channels of Distr ibution
2. Quantitative country performance sections, providing sales trends for:
  • Country ranking amongst 40 markets
  • Audited Market Trend
  • Leading 35 local companies
  • Leading 35 corporations
  • Market Share by Corporate Nationality
  • Leading 15 Therapeutic Classes
  • 15 Fastest-Growing Therapeutic Classes
  • Leading 15 Therapeutic Class Profiles, including trends for top 10 corporations and top 10 products
  • Leading 40 Products
  • Leading 40 New Products
  • Leading 15 product forms
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
-Glaxo Wellcome Bv
-Pharmachemie
-Pfizer Bv
-Astrazeneca
-Merck Sharp Dohme
-Stephar
-Sandoz
-Polyfarma Bv
-Novartis
-Sanofi Aventis
-Ratiopharm
-Altana
-Janssen-Cilag Bv
-Boehringer Ing.
-Wyeth
-Novo-Nordisk Farma
-Actavis
-Hexal Pharma
-Fisher Farma
-Lilly,Eli
-Roche Nederland Bv
-Brocacef
-Centrafarm
-Schering Ag
-Merck Generics
-Pharos
-Apothecon
-U.C.B.Farma Ned.Bv
-Organon Ned Bv
-Medcor
-Astellas Pharma
-Smithkline Beecham
-Amgen B.V.
-Eu-Pharma
-Schering-Plough
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll